Ceptaris Seeking Success via Single-Asset Solution
By Marie Powers
Thursday, August 30, 2012
Going against the grain, Ceptaris Therapeutics Inc. is seeking to parlay a single asset in a rare form of cancer into both clinical and financial success.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.